CSNK1G1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.398600E-01
Normal-vs-Stage2
4.894600E-01
Normal-vs-Stage3
6.071900E-02
Normal-vs-Stage4
7.510000E-01
Stage1-vs-Stage2
1.147370E-01
Stage1-vs-Stage3
3.855900E-02
Stage1-vs-Stage4
4.944800E-01
Stage2-vs-Stage3
8.557500E-02
Stage2-vs-Stage4
7.582600E-01
Stage3-vs-Stage4
1.287550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.144400E-01
Normal-vs-AfricanAmerican
9.496600E-01
Normal-vs-Asian
2.212000E-01
Caucasian-vs-AfricanAmerican
4.119400E-01
Caucasian-vs-Asian
2.579400E-01
AfricanAmerican-vs-Asian
1.367010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.939400E-01
Normal-vs-Female
5.300200E-01
Male-vs-Female
7.569000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.269800E-01
Normal-vs-Age(41-60Yrs)
9.994000E-01
Normal-vs-Age(61-80Yrs)
2.775800E-01
Normal-vs-Age(81-100Yrs)
3.315600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.528550E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.046050E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.044200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.983200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.207700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.692800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.531000E-01
Normal-vs-Daily Drinker
3.246800E-01
Normal-vs-Weekly Drinker
3.513000E-01
Normal-vs-Occasional Drinker
7.888800E-01
Normal-vs-Social Drinker
7.056000E-01
Non Drinker-vs-Daily Drinker
7.257800E-01
Non Drinker-vs-Weekly Drinker
9.174200E-01
Non Drinker-vs-Occasional Drinker
1.324230E-01
Non Drinker-vs-Social Drinker
1.968810E-01
Daily Drinker-vs-Weekly Drinker
8.580400E-01
Daily Drinker-vs-Occasional Drinker
2.552600E-01
Daily Drinker-vs-Social Drinker
3.411200E-01
Weekly Drinker-vs-Occasional Drinker
2.756000E-01
Weekly Drinker-vs-Social Drinker
3.450800E-01
Occasional Drinker-vs-Social Drinker
8.740600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.999200E-01
Normal-vs-Grade 2
9.828800E-01
Normal-vs-Grade 3
9.282800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.593600E-01
Grade 1-vs-Grade 3
2.580600E-01
Grade 1-vs-Grade 4
9.999200E-01
Grade 2-vs-Grade 3
2.271600E-01
Grade 2-vs-Grade 4
9.828800E-01
Grade 3-vs-Grade 4
9.282800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.645200E-01
Normal-vs-NonDiabetic
4.781400E-01
Diabetic-vs-NonDiabetic
1.961150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.556000E-01
Normal-vs-NoPancreatitis
4.206400E-01
Pancreatitis-vs-NoPancreatitis
1.355230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.054800E-01
Normal-vs-N1
5.452000E-01
N0-vs-N1
4.602600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.735600E-01
Normal-vs-TP53-NonMutant
6.627200E-01
TP53-Mutant-vs-TP53-NonMutant
3.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
